Cargando…
Development of an Immune-Related Prognostic Signature in Breast Cancer
BACKGROUND: Although increased early detection, diagnosis and treatment have improved the outcome of breast cancer patients, prognosis estimation still poses challenges due to the disease heterogeneity. Accumulating data indicated an evident correlation between tumor immune microenvironment and clin...
Autores principales: | Xie, Peiling, Ma, Yuying, Yu, Shibo, An, Rui, He, Jianjun, Zhang, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997532/ https://www.ncbi.nlm.nih.gov/pubmed/32047513 http://dx.doi.org/10.3389/fgene.2019.01390 |
Ejemplares similares
-
A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape
por: Xie, Peiling, et al.
Publicado: (2021) -
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022) -
Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021) -
Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021) -
Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)